1 Result for "

2230821-27-7

" in MedChemExpress (MCE) Product Catalog:
Products (1)

1 Results for "2230821-27-7" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-123921
CAS No.: 2230821-27-7
Purity:  99.98%
Target:  

PROTACs EGFR

Research Areas:  

Cancer

Gefitinib-based PROTAC 3 is a PROTAC degrader targeting EGFR, with a DC50 of 11.7 nM against exon 19 deletion mutants and a DC50 of 22.3 nM against EGFR L858R. Gefitinib-based PROTAC 3 selectively induces the ubiquitin-proteasome degradation of exon 19 deletion-mutant and L858R-mutant EGFR by recruiting the VHL E3 ligase. Gefitinib-based PROTAC 3 can be used for the research of EGFR mutation-positive cancers .
loading...
    loading...